OR WAIT null SECS
The Pulmonary Fibrosis Foundation (PFF) launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis (PF) community search for different treatment options currently in development for interstitial lung diseases.
Building off PFF’s Clinical Trials Education Center, the Pipeline tool features news about recent drug and study announcements, as well as links to relevant trials on the Clinical Trial Finder page to ensure patients are aware of opportunities to participate in clinical trials targeted at their specific conditions. The tool allows viewers to filter search results by study phase, disease/condition, intervention type and more.
In addition, users can access a Drug Development Pipeline Glossary to better understand the development process, and a user feedback form to share any questions or concerns they have with the tool to aid in future enhancements.
In addition, the PFF connects PF researchers to valuable medical information from more than 2,000 patient volunteers through the PFF Patient Registry. This research tool offers a combination of data from a wide range of patients, including those with less-studied forms of PF, to generate a resource for future research into treatments and provides data for improving and reassessing existing care guidelines.